Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 18, 2014
Jurisdiction: Nevada
Principal Executive Office: Boca Raton, FL
This filing serves as a Regulation FD disclosure to furnish an investor presentation (Exhibit 99.1) intended for use on November 18, 2014, and at subsequent meetings with investors or analysts.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the existence of an investor presentation rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The primary event is the distribution of the attached investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The company is furnishing an investor presentation dated November 2014. The content of this presentation is subject to modification.
Legal Status of Information: The information in this Current Report and its exhibits is furnished pursuant to Item 7.01 of Form 8-K. It is not deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. Furthermore, the information will not be incorporated by reference into any other filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as expressly set forth by specific reference.
Key Facts for Investor Verification
- Verify the content of the investor presentation (Exhibit 99.1) separately, as the 8-K text does not contain the financial data or strategic details.
- Note that the information provided is not legally "filed" and carries different liability standards than standard financial reports.
- Confirm if the presentation has been modified since the November 18, 2014 date, as the filing states it is subject to modification.